Pharmacy Times

NOVEMBER 5, 2022

Healthcare practitioner finds that institutions need to acknowledge advantaged and disadvantaged groups of patients as motivation to overcome systemic barriers.

132

132

The Guardian - Pharmaceutical Industry

NOVEMBER 5, 2022

Brexit fallout plus funding fears mean an uncertain prognosis, but the firm should report good news this week Rishi Sunak has vowed to make the UK a “science and technology superpower”, following in the footsteps of prime ministers including David Cameron, who called life sciences the “jewel in the crown” of our economy. But Britain’s pivot away from Europe has cast a shadow, and raises questions for national champions such as AstraZeneca, the country’s largest drugmaker, which reports third-qua

64

64

Pharmacy Times

NOVEMBER 5, 2022

Pharmacists should get out from behind the glass from time to time and work with chronic kidney disease patients to better understand their medications and lifestyle decisions, said an analyst who spoke at ASN Kidney Week in Orlando, Florida.

123

123

Pharmacy Times

NOVEMBER 5, 2022

FDA Commissioner Robert Califf said that misinformation is the most common cause of death in the United States.

FDA 139

FDA 139

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

NOVEMBER 5, 2022

In addition to the ongoing COVID-19 pandemic, significant public health concerns include opioid overdoses, maternal mortality disparities, and climate change.

144

144